Bang-Chool Kim, Ph.D. - Publications
Affiliations: | 2001 | Ohio State University, Columbus, Columbus, OH |
Area:
Physical EducationYear | Citation | Score | |||
---|---|---|---|---|---|
2019 | Kim SY, Kim SM, Chang H, Kim BW, Lee YS, Chang HS, Park CS. Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea. Frontiers in Endocrinology. 10: 384. PMID 31244783 DOI: 10.3389/fendo.2019.00384 | 0.307 | |||
2018 | Lee YS, Kim SM, Kim BW, Chang HJ, Kim SY, Park CS, Park KC, Chang HS. Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells. Neoplasia (New York, N.Y.). 20: 197-206. PMID 29331886 DOI: 10.1016/j.neo.2017.12.003 | 0.315 | |||
2017 | Park KC, Kim SM, Jeon JY, Kim BW, Kim HK, Chang HJ, Lee YS, Kim SY, Choi SH, Park CS, Chang HS. Synergistic activity of N-hydroxy-7-(2-naphthylthio) heptanomide and sorafenib against cancer stem cells, anaplastic thyroid cancer. Neoplasia (New York, N.Y.). 19: 145-153. PMID 28142087 DOI: 10.1016/j.neo.2016.12.005 | 0.315 | |||
2012 | Garg K, Rockman CB, Kim BJ, Jacobowitz GR, Maldonado TS, Adelman MA, Veith FJ, Cayne NS. Outcome of endovascular repair of popliteal artery aneurysm using the Viabahn endoprosthesis. Journal of Vascular Surgery. 55: 1647-53. PMID 22608040 DOI: 10.1016/j.jvs.2011.12.059 | 0.488 | |||
Show low-probability matches. |